Published in Diabetes on July 01, 1999
Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest (2004) 1.91
Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production. Am J Physiol Heart Circ Physiol (2009) 1.22
Endothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency. Hypertension (2009) 1.06
PPARgamma and its ligands: therapeutic implications in cardiovascular disease. Clin Sci (Lond) (2009) 1.03
Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature? J Biol Chem (2010) 1.00
Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol (2008) 0.99
Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. Microcirculation (2009) 0.92
Peroxisome proliferator-activated receptor gamma ligands and atherosclerosis: ending the heartache. J Clin Invest (2000) 0.91
Effect of rosiglitazone on bone quality in a rat model of insulin resistance and osteoporosis. Diabetes (2011) 0.89
Microvascular responsiveness in obesity: implications for therapeutic intervention. Br J Pharmacol (2012) 0.88
The role of peroxisome proliferator-activated receptors in pulmonary vascular disease. PPAR Res (2007) 0.87
Hypoxia-inducible factor-1α in vascular smooth muscle regulates blood pressure homeostasis through a peroxisome proliferator-activated receptor-γ-angiotensin II receptor type 1 axis. Hypertension (2013) 0.83
Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction. Physiol Genomics (2015) 0.83
PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system? World J Cardiol (2011) 0.82
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats. Exp Biol Med (Maywood) (2012) 0.82
Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats. Cardiovasc Diabetol (2014) 0.81
Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta. Br J Pharmacol (2003) 0.81
Peroxisome proliferator-activated receptors in diabetic nephropathy. PPAR Res (2009) 0.81
Physiological responses to acute psychological stress are reduced by the PPARγ agonist rosiglitazone. Endocrinology (2012) 0.80
Insulin resistance as a contributor to myocardial ischaemia independent of obstructive coronary atheroma: a role for insulin sensitisation? Heart (2004) 0.78
Modern pharmacotherapies for type 2 diabetes mellitus. J Natl Med Assoc (2001) 0.75
Can the electrophysiological action of rosiglitazone explain its cardiac side effects? Curr Med Chem (2011) 0.75
Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats. ISRN Pharmacol (2012) 0.75
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 12.66
Emergence of vancomycin-resistant enterococci in New York City. Lancet (1993) 7.37
Isolation of a tumor factor responsible for angiogenesis. J Exp Med (1971) 7.12
Rationale and standards for the systematic review of qualitative literature in health services research. Qual Health Res (1998) 6.95
Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation. Ann Rheum Dis (1998) 5.76
Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet (1987) 4.97
Differing patterns of temporal atrophy in Alzheimer's disease and semantic dementia. Neurology (2001) 4.10
Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet (1999) 3.92
A community training scheme in cardiopulmonary resuscitation. Br Med J (Clin Res Ed) (1984) 3.83
A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction. Br Med J (1974) 3.80
Public health research and lay knowledge. Soc Sci Med (1996) 3.72
The genesis of chronic illness: narrative re-construction. Sociol Health Illn (1984) 2.87
Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin Cancer Res (2001) 2.35
Spatial analysis of notified dengue fever infections. Epidemiol Infect (2010) 2.34
Maintenance of remission in ulcerative colitis with oral preparation of 5-aminosalicylic acid. Br Med J (Clin Res Ed) (1982) 2.32
Isolation and characterization of the cDNA encoding BKLF/TEF-2, a major CACCC-box-binding protein in erythroid cells and selected other cells. Mol Cell Biol (1996) 2.31
The EPHESUS trial: eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. Eplerenone Post-AMI Heart Failure Efficacy and Survival Study. Cardiovasc Drugs Ther (2001) 2.13
Developmental regulation of IgM secretion: the role of the carboxy-terminal cysteine. Cell (1990) 2.12
HIV infection in Manchester, 1959. Lancet (1990) 2.08
Effects of chronic vanadate administration in the STZ-induced diabetic rat. The antihyperglycemic action of vanadate is attributable entirely to its suppression of feeding. Diabetes (1994) 2.07
Cardiff Crohn's disease jubilee: the incidence over 50 years. Gut (1988) 2.05
Inflammatory aneurysms of the abdominal aorta. Br J Surg (1972) 2.05
Bladder cancer as a prescribed industrial disease: a guide for clinicians. Br Med J (1980) 1.99
An examination of John Fewster's role in the discovery of smallpox vaccination. J R Coll Physicians Edinb (2015) 1.97
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist. Br Med J (Clin Res Ed) (1983) 1.93
Gastric assessment of prospective renal-transplant patients. Lancet (1972) 1.89
Distribution of genes for trimethoprim and gentamicin resistance in bacteria and their plasmids in a general hospital. J Gen Microbiol (1980) 1.84
Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother (2010) 1.83
BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol (1986) 1.79
10 Years of infective endocarditis at St. Bartholomew's Hospital: analysis of clinical features and treatment in relation to prognosis and mortality. Lancet (1980) 1.78
Squamous cell carcinoma of bronchus presenting with Henoch-Schönlein purpura. Br Med J (1978) 1.78
IgM associated primary diffuse mesangial proliferative glomerulonephritis. J Clin Pathol (1980) 1.75
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell (1998) 1.75
Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes (2001) 1.75
Urothelial malignant disease and Chinese herbal nephropathy. Lancet (2001) 1.73
Human insulin and awareness of acute hypoglycaemic symptoms in insulin-dependent diabetes. Lancet (1991) 1.71
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
Cellular localisation of human urogastrone/epidermal growth factor. Nature (1978) 1.60
Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J Clin Microbiol (1999) 1.60
Essential fatty acids and fetal brain growth. Lancet (1976) 1.58
Physiologic consequences of positive end-expiratory pressure (PEEP) ventilation. Ann Surg (1973) 1.58
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study. Psychol Med (2008) 1.55
Neonatal transport: a controlled study of skilled assistance. Mortality and morbidity of neonates less than 1.5 kg birth weight. J Pediatr (1978) 1.55
Mortality and outcome of patients with brittle diabetes and recurrent ketoacidosis. Lancet (1994) 1.54
Goya's deafness. Pract Neurol (2008) 1.53
Non-invasive detection of hypoglycaemia using a novel, fully biocompatible and patient friendly alarm system. BMJ (2001) 1.53
Identification and characterization of multiple species of vancomycin-resistant enterococci, including an evaluation of Vitek software version 7.1. J Clin Microbiol (1993) 1.52
The products of the kdpDE operon are required for expression of the Kdp ATPase of Escherichia coli. J Bacteriol (1992) 1.51
Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol (1996) 1.51
Health promotion--caring concern or slick salesmanship? J Med Ethics (1984) 1.51
Changes in blood flow close to subcutaneous insulin injection sites in stable and brittle diabetics. Diabetes (1983) 1.51
Effects of short-term feeding of a highly palatable diet on vascular reactivity in rats. Eur J Clin Invest (2001) 1.50
Strong association between idiopathic membranous nephropathy and HLA-DRW3. Lancet (1979) 1.50
High diversity and widespread occurrence of mitotic spore mats in ectomycorrhizal Pezizales. Mol Ecol (2012) 1.49
Qualitative research and evidence-based healthcare. J R Soc Med (1998) 1.48
Generation and analysis of 25 Mb of genomic DNA from the pufferfish Fugu rubripes by sequence scanning. Genome Res (1999) 1.47
Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol (2006) 1.47
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus. Lupus (2009) 1.47
A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines. Regul Toxicol Pharmacol (1999) 1.47
In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone. Circulation (2001) 1.46
Adhesions of the labia minora. Br J Urol (1996) 1.46
Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology (1998) 1.45
Hospital mortality under surgical care. Ann R Coll Surg Engl (2011) 1.45
Excessive impertinence or a missed diagnosis? BMJ (1996) 1.45
Nurses' confidence and pharmacological knowledge: a study. Br J Community Nurs (2002) 1.44
Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes (1997) 1.44
The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology (2000) 1.43
Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation. Br J Urol (1989) 1.43
Length polymorphism in the pro alpha 2(I) collagen gene: an alternative explanation in a case of Marfan syndrome. Hum Genet (1986) 1.41
Intraarticular corticosteroid injections: should we rest the joints? Arthritis Care Res (1989) 1.41
Symptoms versus flow rates versus urodynamics in the selection of patients for prostatectomy. Br J Urol (1990) 1.41
VEGF localisation in diabetic retinopathy. Br J Ophthalmol (1998) 1.40
Observation of B(0)(s)-->Psi(2S)Phi and measurement of the ratio of branching fractions Beta(B(0)(s)-->Psi(2S)Phi)/Beta(B(0)(s)-->J/PsiPhi). Phys Rev Lett (2006) 1.40
Nifedipine and nocturia. Lancet (1986) 1.40
Pregnancy-induced hypertension and renal failure: clinical importance of diuretics, plasma volume and vasospasm. Aust N Z J Obstet Gynaecol (1989) 1.39
Extra-urethral urinary incontinence after incompetent vaginal obstetrics. BJU Int (1999) 1.38
Bilateral one-stage carotid endarterectomy--Is there an indication? Eur J Vasc Endovasc Surg (2001) 1.38
The benefits of low-dose aspirin therapy in women with impaired uterine perfusion during assisted conception. Hum Reprod (1994) 1.38
Pre-excitation due to accessory sinoventricular connexions associated with coronary sinus aneurysms. A report of two cases. Br Heart J (1985) 1.38
Effective treatment of insulin-induced edema using ephedrine. Diabetes Care (1993) 1.37
Unilateral pupil dilation following head injury: thinking outside the (brain) box. QJM (2010) 1.37
Histological evaluation of Permacol as a subcutaneous implant over a 20-week period in the rat model. Br J Plast Surg (2005) 1.35
Structural studies of the acidic transactivation domain of the Vmw65 protein of herpes simplex virus using 1H NMR. Biochemistry (1992) 1.35
Uclacyanins, stellacyanins, and plantacyanins are distinct subfamilies of phytocyanins: plant-specific mononuclear blue copper proteins. Protein Sci (1998) 1.35
Role of lymphography in carcinoma of the prostate. Br Med J (1975) 1.34
The mental health of women 6 months after they give birth to an unwanted baby: a longitudinal study. Soc Sci Med (1991) 1.33
Differing interpretations by pathologists of the pT category and grade of transitional cell cancer of the bladder. Br J Urol (1988) 1.30
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. Int J Obes Relat Metab Disord (2000) 1.30
The Brisbane floods, January 1974: their impact on health. Med J Aust (1977) 1.29
Bladder cancer as a prescribed industrial disease. Br Med J (1980) 1.28
Chromosomal mutations causing resistance to tetracycline in Bacillus subtilis. Mol Gen Genet (1979) 1.28
Risk factors in the development of ocular surface epithelial dysplasia. Ophthalmology (1994) 1.28
Maternal exposure to low levels of ambient air pollution and preterm birth in Brisbane, Australia. BJOG (2006) 1.26
Systemic fat embolism in four combat casualities. Ann Surg (1968) 1.26
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. Br Med J (Clin Res Ed) (1984) 1.25
Computed tomography for determining liver iron content in primary haemochromatosis. Br Med J (1980) 1.25
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth. J Biol Chem (2001) 1.24
Cryoglobulins. III. Further studies on the nature, incidence, clinical, diagnostic, prognostic, and immunopathologic significance of cryoproteins in renal disease. Q J Med (1975) 1.24